Telmisartan, An Angiotensin II Type 1 Receptor Blocker, Controls Progress of Nonalcoholic Steatohepatitis in Rats
- 5 April 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in Digestive Diseases and Sciences
- Vol. 52 (12), 3455-3464
- https://doi.org/10.1007/s10620-007-9741-4
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Telmisartan But Not Valsartan Increases Caloric Expenditure and Protects Against Weight Gain and Hepatic SteatosisHypertension, 2006
- Regulation of Peroxisome Proliferator–Activated Receptor γ Activity by Losartan MetabolitesHypertension, 2006
- Pioglitazone improves insulin sensitivity through reduction in muscle lipid and redistribution of lipid into adipose tissueAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Deficiency of inducible nitric oxide synthase exacerbates hepatic fibrosis in mice fed high-fat dietBiochemical and Biophysical Research Communications, 2004
- Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonistsJournal of Hypertension, 2004
- Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPARγ–Modulating ActivityHypertension, 2004
- Acarbose attenuates experimental non-alcoholic steatohepatitisBiochemical and Biophysical Research Communications, 2004
- Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient l-amino acid-defined dietBiochemical and Biophysical Research Communications, 2004
- Angiotensin II receptor blockade in TGR(mREN2)27: effects of renin???angiotensin-system gene expression and cardiovascular functionsJournal of Hypertension, 1995
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970